Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$6.5b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

Tong Ren Tang Technologies

Market Cap: HK$5.1b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Consun Pharmaceutical Group

Market Cap: HK$14.6b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.8b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

Essex Bio-Technology

Market Cap: HK$2.0b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

Shanghai Haohai Biological Technology

Market Cap: HK$9.3b

Shanghai Haohai Biological Technology Co., Ltd.

China Shineway Pharmaceutical Group

Market Cap: HK$6.9b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

Pak Fah Yeow International

Market Cap: HK$741.7m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.7b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

Jacobson Pharma

Market Cap: HK$2.5b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.